What's new

Filters: policy
x
Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Policy recommendations on uptake of biosimilar medicines in the retail market

5 November 2021

Policy

Policy recommendations on uptake of biosimilar medicines in the retail […]

Read more

Positioning Statements on Physician-led Switching for Biosimilar Medicines

1 October 2021

Policy

Positioning statements on physician-led switching for biosimilar medicines (October 2021) […]

Read more

Position Paper. Incentives Review The Orphan and Paediatric Incentives

1 March 2021

Policy

Read More

Second wave pandemic preparedness: procurement principles

24 August 2020

Policy

Read More

Policy Roadmap for Medicines Manufacturing Leadership

6 July 2020

Policy

Read More

Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns

25 June 2020

Policy

Read More

Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney

22 June 2020

Policy

Read More

LESSONS LEARNED FROM COVID-19 – POLICY PAPER

22 June 2020

Policy

Read More

Open letter to the Members of the European Parliament on the importance to sustain EU progress in fighting against antimicrobial resistance (AMR)

11 September 2019

Policy

Read More

Medicines for Europe Commentary on the Draft EMA regulatory science strategy 2025

28 June 2019

Policy

Read More

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]